Effects of sulphasalazine and its metabolites on prostaglandin synthesis, inactivation and actions on smooth muscle
about
Sulphasalazine in ankylosing spondylitis.Effects of sulphasalazine and disodium azodisalicylate on colonic PGE2 concentrations determined by equilibrium in vivo dialysis of faeces in patients with ulcerative colitis and healthy controls.The protective effects of sulphasalazine against ethanol-induced gastric damage in ratsSulphasalazine and PhCL28A inhibit the formation of ethanol- and phenylbutazone-induced rat gastric ulcers: lack of involvement of endogenous prostaglandins?Sulphasalazine in ulcerative colitis: in memoriam?Inflammatory intermediaries in inflammatory bowel disease.Chemically induced renal papillary necrosis and upper urothelial carcinoma. Part 1.Chemically induced renal papillary necrosis and upper urothelial carcinoma. Part 2.Ulcerative colitis: effect of sulphasalazine, its metabolites and indomethacin on the ability of human colonic mucosa to metabolize prostaglandins in vitro.Effect of sulphasalazine on pulmonary inactivation of prostaglandin F2 alpha in the pig.Effect of sulphasalazine and sulphapyridine on neutrophil superoxide production: role of cytosolic free calcium.Effect of sulphasalazine and its metabolites on the generation of reactive oxygen species.Mechanism of action of 5-arninosalicylic acid.Nuclear factor κB is a key transcription factor in the duodenal contractility alterations induced by lipopolysaccharide.Increased suppressor cell activity in inflammatory bowel disease.Intrarectal administration of 5-aminosalicylic acid to rabbits and dogs.Effects of prostaglandin E2 (PGE2) and drugs affecting PGE2 degradation on acute rejection of rat cardiac allografts.
P2860
Q33556616-A957E205-11DF-4DEC-AC02-D882F813A91BQ34525348-CB57C2EB-4AC9-4E64-9AAF-06C4DAEA1BB3Q35754888-F78E38E8-5CE5-466F-8B79-C45D4A9CC572Q35755379-D20591B4-AB85-431B-96F4-CD2794FF7A8DQ36495618-3066CC2A-1DF5-4075-8603-A0833D9AA31CQ38660602-DA54F532-3CC2-4246-9ADA-2A82452C562BQ39849913-2E32B521-791C-4DF8-AE39-69C494FE0FD2Q39850291-7A69FC48-893C-4640-A980-8FAD6D39FC58Q39856402-7BE20777-246F-4C5B-AA59-F64F1AF2C074Q39931852-EC251475-A2FC-48FD-8092-BDD2B7706345Q41222035-74DE6C2F-C24C-470B-BF5F-AB42AA6425C9Q41830145-EDEB9067-82AC-49ED-9C41-D3976E934BEBQ42106723-E054E962-3A39-41EE-B930-35D83F07A34CQ42727071-BAF64C06-D428-4DA0-B1C3-F71FA5F58249Q43255584-C1C97334-3E5A-4039-8C68-CA2F48525B76Q44053183-4E3F129F-E4AB-44D4-8A0D-E44192FC70C4Q45256907-5F6F1B5C-8C41-489F-84A3-69D752FBC6F0
P2860
Effects of sulphasalazine and its metabolites on prostaglandin synthesis, inactivation and actions on smooth muscle
description
1980 nî lūn-bûn
@nan
1980年の論文
@ja
1980年論文
@yue
1980年論文
@zh-hant
1980年論文
@zh-hk
1980年論文
@zh-mo
1980年論文
@zh-tw
1980年论文
@wuu
1980年论文
@zh
1980年论文
@zh-cn
name
Effects of sulphasalazine and ...... n and actions on smooth muscle
@ast
Effects of sulphasalazine and ...... n and actions on smooth muscle
@en
type
label
Effects of sulphasalazine and ...... n and actions on smooth muscle
@ast
Effects of sulphasalazine and ...... n and actions on smooth muscle
@en
prefLabel
Effects of sulphasalazine and ...... n and actions on smooth muscle
@ast
Effects of sulphasalazine and ...... n and actions on smooth muscle
@en
P2860
P1476
Effects of sulphasalazine and ...... n and actions on smooth muscle
@en
P2093
P2860
P304
P356
10.1111/J.1476-5381.1980.TB10865.X
P407
P577
1980-04-01T00:00:00Z